Tola AJ, Leelawatwattana L, Prapunpoj P. The catalytic kinetics of chicken transthyretin towards human Aβ
1-42.
Comp Biochem Physiol C Toxicol Pharmacol 2019;
226:108610. [PMID:
31454704 DOI:
10.1016/j.cbpc.2019.108610]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/11/2019] [Revised: 08/16/2019] [Accepted: 08/22/2019] [Indexed: 12/25/2022]
Abstract
The novel property of transthyretin (TTR) as a protease has been proposed to be significant. However, the study of TTR proteolysis properties has not been completely elucidated. Herein, we first report the catalytic activity of chicken TTR from plasma determined by using fluorescently labeled amyloid beta 1-42 peptide (Aβ1-42), and compared it with human TTR (human TTR) from plasma and recombinant Crocodylus porosus TTR. The enzyme kinetic study revealed that the affinity for Aβ1-42 of chicken TTR and C. porosus TTR (KM values were 12.72 ± 0.27 μM and 16.21 ± 0.02 μM, respectively) were significantly lower than human TTR (KM was 43.05 ± 0.39 μM). In addition, the catalytic efficiency of chicken TTR (Kcat/KM was 310,386.87 ± 13,627.12 M-1 s-1) was 4.3 and 5.5 folds higher than those of C. porosus TTR and human TTR (Kcat/KM were 72,893.80 ± 355.74 M-1 s-1 and 56,519.12 ± 5009.50 M-1 s-1, respectively), respectively. These results does not only indicated the relationship between structure and the proteolytic activity of TTR, but also suggested a potential development of TTR as a therapeutic anti-Aβ agent.
Collapse